Trial Profile
Pharmacokinetic study of golimumab in pediatric ulcerative colitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Aug 2018
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 14 Aug 2018 New trial record